Fluorescence resonance energy transfer technique IDs kinase activity in chronic myeloid leukemia [more]

Appears to prolong overall survival in men with metastatic castration-resistant prostate cancer [more]

Findings suggest unnecessary expenses related to continuing care [more]

Detection threshold limitations, not faster doubling times, usually cause screening failures [more]

Higher scores especially predictive of estrogen receptor-positive disease [more]

Acceptable accordance regarding adverse events seen up to 24 months in prostate cancer patients [more]

View all news

What To Do When You're Blind in One Eye New blog post from Rodney Warner, JD Management of Chemotherapy-Induced Dysgeusia - Continuing Education This continuing education activity is designed for nurses in clinical practice to learn about the nursing management and treatment of patients experiencing chemotherapy-induced dysgeusia. Ask The Experts OncoLink "Ask the Experts" questions answered by our panel of medical experts online. Taking AIs Beyond 5 Years PSA Testing in Older Men CancerLand Bookshelf: My One-Night Stand with Cancer New blog post from Alysa Cummings Second Opinions New Bob Riter Cancer Column Greetings from CancerLand: Donations Gratefully Accepted New blog from Alysa Cummings A Dietitian's Strange Affair with Sugar Latest Nutrition Nuggests blog: from Karen Wagner, MS, RD, LDN Grace: A Child’s Intimate Journey Through Cancer And Recovery OnoLink Book Review from Alysa Cummings Stage II Colon Cancer: To Treat or Not to Treat? A diagnosis of colon cancer can bring about many emotions and feelings of uncertainty. A stage II colon cancer adds an additional layer of uncertainty – to treat or not to treat? OncoLink at ASCO 2010 OncoLink reporters provide in-depth coverage of scientific presentations from the 46th Annual ASCO Meeting. Brown Bag Chat: Cancer Survivorship Archive from the June 10th webchat on cancer survivorship. Patient Perceptions of Proton Therapy: An Internet Based Survey This survey will help us to understand common patient perceptions of proton therapy - an increasingly popular form of external radiation treatment. View All What's New | What's New RSS

OncoLink's blogs gives our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other. Join the Conversation!

Latest Posts:
What To Do When You're Blind in One Eye from Rodney Warner, JD
CancerLand Bookshelf: The Cancer Monologue Project from Alysa Cummings

Transcript from Brown Bag Chat: Cancer Survivorship

See all recent posts [RSS]

OncoLink has teamed up with the Lance Armstrong Foundation to create an individualized plan of care based on the Institute of Medicine recommendations for cancer survivors. This free and easy to use program provides cancer survivors with information regarding the health risks they face as a result of cancer therapies. It encourages them to review the plan with their healthcare team to further assess their risk and become active participants in their follow up care.

Develop your survivorship care plan today!

en espanõl

Skin cancer is the number one cancer diagnosis in the United States - more common than all breast, prostate, and lung cancers combined. The majority of cases are caused by sun damage to skin cells, and therefore are largely preventable. Every year in July we recognize UV Safety month to remind people of the importance of sun safety. Get the facts.

Proton therapy is an advanced form of radiation therapy that is currently in use at a limited number of centers worldwide. Learn more about this exciting therapy!